Showing 6691-6700 of 9553 results for "".
- Alastin to be Acquired by Galdermahttps://practicaldermatology.com/news/alastin-to-be-acquired-by-galderma/2460997/Galderma is set to acquire Alastin Skincare®, Inc. The world’s largest independent dermatology company has signed a definitive agreement to acquire the specialty aesthetics company dedicated to developing innovative and clinically-tested physician-dispensed skincare products. Financial
- Novel Lyme Vaccine Shows Promise in Early Researchhttps://practicaldermatology.com/news/novel-lyme-vaccine-shows-promise-in-early-research/2460994/Yale University researchers have developed a novel vaccine that in guinea pigs offers protection against infection by the bacterium that causes Lyme disease and may also combat other tick-borne diseases, they report in the journal Science Translational Medicine. Instead of trig
- Abreva Launches #StopBullyingYourself Campaign for People with Cold Soreshttps://practicaldermatology.com/news/abreva-launches-stopbullyingyourself-campaign-for-people-with-cold-sores/2460993/People with cold sores tend to beat themselves up, according to a new survey from Abreva. As many as 80 percent of people with cold sores feel misunderstood and want others to know it is a common affliction and that cold sores do not mean that they are
- National Rosacea Society Awards 2021 Research Grantshttps://practicaldermatology.com/news/national-rosacea-society-awards-2021-research-grants/2460988/The National Rosacea Society has awarded funding for two new studies in addition to continuing support for two ongoing studies as part of its
- With New Agreement, DermTech Melanoma Test Available Through DermatologistOnCallhttps://practicaldermatology.com/news/with-new-agreement-dermtech-melanoma-test-available-through-dermatologistoncall/2460987/The DermTech Melanoma Test is now available through DermatologistOnCall’s telemedicine platform. The DermTech Melanoma Test is a non-invasive test used to painlessly collect cellular material from the surface of a patient’s mole via t
- Better Together: Castle Biosciences’ Full DecisionDx Portfolio to Be Interfaced with ModMed’s EMAhttps://practicaldermatology.com/news/better-together-castle-biosciences-full-decisiondx-portfolio-to-be-interfaced-with-modmeds-ema/2460982/Castle Biosciences, Inc’s full DecisionDx portfolio of dermatologic tests will be interfaces with EMA, ModMed’s electronic health records system, by year-end 2021 The interface is designed to enable dermatologic clinicians to order Castle’s De
- FDA Fast Tracks Union Therapeutics' AD Candidatehttps://practicaldermatology.com/news/fda-fast-tracks-union-therapeutics-ad-candidate/2460978/The US Food and Drug Administration (FDA) has granted Fast Track designation to Union Therapeutics’ oral orismilast for the treatment of moderate to severe atopic dermatitis (AD). Orismilast is a next generation PDE4 inhibitor with broad anti-inflammatory properti
- Sun Pharma’s WINLEVI for Acne Now Availablehttps://practicaldermatology.com/news/sun-pharmas-winlevi-for-acne-now-available/2460974/WINLEVI (clascoterone) cream 1% is now available the US, according to Sun Pharmaceutical Industries Limited. A first-in-class topical androgen receptor inhibitor, WINLEVI was approved by FDA in August 2020 for the topical treatment of acne vulgaris in patients 12 yea
- IFPA Calls for Action Against Psoriasishttps://practicaldermatology.com/news/ifpa-calls-for-action-against-psoriasis/2460971/Today is World Psoriasis Day, and the International Federation of Psoriasis Associations (IFPA) is launching a global petition to demand progress. In 2014, all UN nations unanimously voted to approve the Resolution on Psoriasis (WHA 67.9), committing to improve the l
- Crown Aesthetics Launches SkinPen Precision Ambassador Programhttps://practicaldermatology.com/news/crown-aesthetics-launches-skinpen-precision-ambassador-program/2460968/Crown Aesthetics announced the launch of their SkinPen Ambassador Program in conjunction with National Microneedling Day. The SkinPen Ambassador Program presents current SkinPen providers with the opportunity to showcase their practice success and to share valuable insights and SkinPen